Literature DB >> 20195682

Head and neck sarcoma: report of a case treated by intensity-modulated radiation therapy.

Pierre Heudel1, Marie Claude Biston, Jérome Fayette, Antoine Ramade, Frédéric Gassa, Pascal Pommier.   

Abstract

We report on a 71-year-old woman with parapharyngeal sarcoma. Surgery could not be performed because of the size and location of the tumor. After failure of four cycles of chemotherapy, intensity-modulated radiation therapy (IMRT) achieved complete clinical response and partial magnetic resonance imaging response (80%) at 24 months of follow-up. The results of radiotherapy, especially IMRT, for nonresectable head and neck soft tissue sarcoma are discussed.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20195682     DOI： 10.1007/s10147-010-0037-x

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


  50 in total

1.  Proton beam radiation therapy for skull base adenoid cystic carcinoma.

Authors:  Pascal Pommier; Nobert J Liebsch; Daniel G Deschler; Derrick T Lin; James F McIntyre; Fred G Barker; Judy A Adams; Vrishali V Lopes; Mark Varvares; Jay S Loeffler; Annie W Chan
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-11

2.  The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: review of 30 cases.

Authors:  Merdan Fayda; Gorkem Aksu; Fulya Yaman Agaoglu; Ahmet Karadeniz; Emin Darendeliler; Musa Altun; Gunter Hafiz
Journal:  J Craniomaxillofac Surg       Date:  2008-09-18       Impact factor: 2.078

Review 3.  The role for radiation therapy in the management of patients with sarcoma of soft tissue in 1988.

Authors:  H D Suit
Journal:  Cancer Treat Res       Date:  1989

4.  Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.

Authors:  P W Pisters; L B Harrison; D H Leung; J M Woodruff; E S Casper; M F Brennan
Journal:  J Clin Oncol       Date:  1996-03       Impact factor: 44.544

5.  Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.

Authors:  J M Coindre; P Terrier; N B Bui; F Bonichon; F Collin; V Le Doussal; A M Mandard; M O Vilain; J Jacquemier; H Duplay; X Sastre; C Barlier; M Henry-Amar; J Macé-Lesech; G Contesso
Journal:  J Clin Oncol       Date:  1996-03       Impact factor: 44.544

6.  Soft-tissue sarcomas of the head and neck.

Authors:  A M Freedman; H M Reiman; J E Woods
Journal:  Am J Surg       Date:  1989-10       Impact factor: 2.565

7.  Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.

Authors:  Moody D Wharam; Jane Meza; James Anderson; John C Breneman; Sarah S Donaldson; Thomas J Fitzgerald; Jeff Michalski; Lisa A Teot; Eugene S Wiener; William H Meyer
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

Review 8.  Chemotherapeutic approaches to soft tissue sarcomas.

Authors:  J H Edmonson
Journal:  Semin Surg Oncol       Date:  1994 Sep-Oct

9.  Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.

Authors:  Sheri L DeMartelaere; Dianna Roberts; Michael A Burgess; William H Morrison; Peter W T Pisters; Erich M Sturgis; Viet Ho; Bita Esmaeli
Journal:  Head Neck       Date:  2008-05       Impact factor: 3.147

10.  Head and neck soft tissue sarcomas: a multivariate analysis of outcomes.

Authors:  Brandon G Bentz; Bhuvanesh Singh; James Woodruff; Murray Brennan; Jatin P Shah; Dennis Kraus
Journal:  Ann Surg Oncol       Date:  2004-06       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.